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Monosomy 1p36 is the most common terminal deletion syndrome. This contiguous gene deletion syndrome is
presumably caused by haploinsufficiency of a number of genes. We have constructed a contig of overlapping large-
insert clones for the most distal 10.5 Mb of 1p36, evaluated the deletion sizes in 61 subjects with monosomy 1p36
from 60 families, and created a natural deletion panel. We found pure terminal deletions, interstitial deletions,
derivative chromosomes, and more complex rearrangements. Breakpoints were “binned” into 0.5-Mb regions.
Analyses revealed some clustering of breakpoints but no single common breakpoint. Determination of the parental
origin showed that 60% of de novo 1p36 terminal deletions arose from the maternally inherited chromosome. Of
the 61 subjects, 30 were examined systematically through a protocol at the Texas Children’s Hospital General
Clinical Research Center. Specifically, we report hearing evaluations, palatal and ophthalmological examinations,
echocardiograms, neurological assessments, and thyroid function tests. To our knowledge, this systematicmolecular
and clinical characterization of monosomy 1p36 is the largest and most comprehensive study of this deletion
syndrome to date. Many cytogenetically visible, apparent terminal deletions are more complex than anticipated by
cytogenetics, as revealed at the molecular level by our study. Our clinical findings allow for the more accurate
recognition of the syndrome and for proper medical evaluation.
Introduction
Chromosomal rearrangements occur in ∼0.6% of live
births (Shaffer and Lupski 2000). Unbalanced chromo-
somal abnormalities account for a substantive portion
of mental retardation. A frequent class of cytogenetic
abnormalities is deletion of the telomeric regions of chro-
mosomes. These may cause substantial phenotypic ab-
normalities, because human telomeric regions are rela-
tively gene rich as compared with other regions of the
genome (Saccone et al. 1992). Each human chromosome
is capped with 3–20 kb of repetitive (TTAGGG)n sequence
(Moyzis et al. 1988). Just proximal to this sequence is
∼100–300 kb of repetitive sequence called “telomere-as-
sociated repeats” (TAR) (Flint et al. 1997). The TAR se-
quence can be shared on multiple chromosome ends. The
chromosome-specific unique sequence is proximal (cen-
Received December 23, 2002; accepted for publication February 26,
2003; electronically published April 8, 2003.
Address for correspondence and reprints: Dr. Lisa G. Shaffer, Health
Research and Education Center, Washington State University, 310
North Riverpoint Boulevard, Box 1495, Spokane, WA 99210-1495.
E-mail: lshaffer@wsu.edu
* These authors contributed equally to this work.
† Present affiliation: School of Molecular Biosciences, Washington
State University, and Sacred Heart Medical Center, Spokane, WA.
 2003 by The American Society of Human Genetics. All rights reserved.
0002-9297/2003/7205-0013$15.00
tromeric) to the TAR sequence. Because most human
chromosomes end in light-staining GTG bands, the telo-
meric regions are difficult to visualize cytogenetically.
Thus, telomere region–specific probes for FISH have been
developed to identify small terminal deletions that oth-
erwise might not be seen with conventional cytogenetic
techniques (Knight et al. 1997).
The constitutional deletion of 1p36 results in a syn-
drome with multiple congenital anomalies and mental
retardation (Shapira et al. 1997). The frequency of
monosomy 1p36 was estimated initially to be 1 in
10,000 births, making it one of the most common chro-
mosomal deletions (Shapira et al. 1997). Recently, we
refined this estimated prevalence to 1 in 5,000 (Shaffer
and Lupski 2000), on the basis of the epidemiology of
our large group of patients. As we first described in 13
subjects (Shapira et al. 1997), facial characteristics in-
clude deep-set eyes, flat nasal bridge, asymmetric ears,
and pointed chin (fig. 1). Additional clinical character-
istics include seizures, cardiomyopathy, developmental
delay, and hearing impairment (reviewed by Slavotinek
et al. 1999; Shaffer and Heilstedt 2001).
Chromosome 1p36 alterations, mostly deletions, have
been reported to occur in various neoplasms, including
neuroblastoma, prostate cancer, lung cancer, malignant
melanoma, hepatoma, cervical carcinoma, breast cancer,
colorectal adenocarcinoma, ovarian cancer, and non-
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Figure 1 Six subjects with 1p36 deletions. A, A boy of age 6 years 4 mo, subject 59; B, A girl of age 4 years 6 mo, subject 52; C, A boy
of age 3 years 5 mo, subject 55a; D, a girl of age 10 years 11 mo, subject 55b; E, a girl of age 8 years 8 mo, subject 51; F, A girl of age 3
years 3 mo, subject 47. Note the flat nasal bridge and nose, asymmetric ears, and pointed chin.
Hodgkin lymphoma. The identification of deletions of
1p36 in a subset of neuroblastoma (White et al. 1995;
reviewed by Blatt 2001), ovarian carcinoma (Thompson
et al. 1997), and malignant melanoma (Nelson et al.
1999, 2000) led to the hypothesis that the 1p36 region
contains a number of tumor-suppressor genes and that
deletion of one or more of these genes is involved in the
chain of events that results in malignancy (Blatt 2001).
Previously, we reported molecular findings in 33 sub-
jects with 1p36 constitutional deletions (Wu et al. 1999;
Ballif et al. 2000a) and found variability in the parental
origin, deletion size, and complexity of the chromosom-
al rearrangements. We have expanded this study to 61
subjects with 1p36 deletions, with the ultimate goal of
understanding the mechanism(s) that generate and sta-
bilize terminal deletions. In addition, we have assembled
a physical map of the most telomeric 10.5 Mb of 1p36
and have constructed a natural deletion panel from our
study-subject cell lines. We have also collected clinical
information on 30 of these subjects, through the Texas
Children’s Hospital General Clinical Research Center
(TCH-GCRC). The clinical features in monosomy 1p36
have been defined more clearly, which may allow phe-
notype/genotype correlations to narrow the regions in
which to search and identify causative genes that yield
the various features of this syndrome.
Subjects and Methods
Study Population
Sixty-one subjects from 60 families were ascertained
for this study, through a protocol and consent form ap-
proved by the Institutional Review Board for Human
Subject Research at the Baylor College of Medicine. One
family had two affected children, because of malsegre-
gation of a parental translocation between the short arm
of chromosome 1 and the long arm of chromosome 9.
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Table 1
Microsatellite Markers Used for Initial Screening
of Deletion Size
Microsatellite
Marker
Approximate
Distance from 1p
Telomere
(Mb)
Marker-Containing
Clone
D1S243 1.75 RPCI11-181G12
D1S468 3.25 RPCI5-1092A11
D1S2845 3.75 RPCI11-168B8
D1S2893 4.0 RPCI1-37J18
D1S2660 4.25 RPCI11-493P12
D1S1608 4.35 RPCI5-1096P7
D1S2795 5.0 RPCI3-491M17
D1S2145 5.25 RPCI5-1098C18
D1S2633 5.6 RPCI1-233K16
D1S2870 5.7 RPCI1-120G22
D1S253 5.75 RPCI1-120G22
D1S3041 6.0 RPCI11-58A11
D1S2731 6.1 RPCI1-126A5
D1S2642 6.2 RPCI11-312B8
D1S214 6.35 RPCI11-312B8
D1S2663 6.7 RPCI3-505B13
D1S2694 6.75 RPCI3-453P22
D1S548 6.8 RPCI3-453P22
D1S2666 6.85 RPCI3-453P22
D1S508 7.1 RPCI5-1045M14
D1S1615 7.75 RPCI5-1115A15
D1S160 8.3 RPCI5-963K15
D1S244 10.0 RPCI11-108G8
D1S2736 10.1 RPCI11-108G8
D1S1635 10.4 RPCI11-340B24
Twenty-three subjects were male, and 38 were female.
Although at a lower resolution than the current study,
the molecular characterization for the first 30 subjects
was reported elsewhere (Shapira et al. 1997; Wu et al.
1999). Ballif et al. (2000a) reported the results of sub-
telomeric region–specific FISH for the first 33 subjects.
We obtained blood samples from all subjects and avail-
able parents and established lymphoblastoid cell lines.
In subjects 29 and 31, amniocytes were used for the
molecular investigation. Thirty subjects had clinical eval-
uations at the TCH-GCRC. The clinical investigation
included evaluations by at least one geneticist (H.A.H.
and S.K.S.), an ophthalmologist (R.A.L.), an audiolo-
gist, and a plastic surgeon (S.S.). Other tests included
echocardiogram, electroencephalogram (EEG), auditory
brainstem evoked response (ABER), and thyroid func-
tion tests.
Molecular Analysis
Genomic DNA from blood, lymphoblastoid cell lines,
or cultured amniocytes was prepared by standard pro-
tocols. DNA samples from 61 subjects and available
parents were analyzed with 25 microsatellite markers
(table 1). The initial marker order was obtained from
the Human Chromosome 1 Home Page, and sequence
analysis is from the Wellcome Trust Sanger Institute
(Human Chromosome 1 Home). During the study, the
marker order was adjusted on the basis of new infor-
mation from sequencing, from our mapping efforts, and
from the construction of our natural deletion panel.
These 25 polymorphic markers were used in PCRs to
determine the extent of deletion and the parent of origin.
The PCR products were electrophoresed in 6% dena-
turing polyacrylamide gels and were visualized by auto-
radiography (Shaffer et al. 1993).
FISH
Metaphase chromosomes were prepared using stan-
dard protocols, and FISH was performed with various
large-insert clones from our physical map. Large-insert
clones from 1p36 were selected as FISH probes, on the
basis of the microsatellite results from each study sub-
ject, to narrow the breakpoint regions to 0.5-Mb bins.
These probes were labeled with digoxigenin and were
detected as published previously (Shaffer et al. 1994).
The TAR clone (GS-63M14) was obtained from Genome
Systems (Knight et al. 2000). A chromosome 1q probe
(GS-160H23) (Knight et al. 2000) served as a control
and was labeled with biotin and detected as described
previously (Shaffer et al. 1994). Telomeric FISH for 41
subtelomeric regions was performed on metaphase chro-
mosomes from 60 subjects, through use of the Chromo-
probe Multiprobe-T System (Cytocell), as published pre-
viously (Knight et al. 1997; Ballif et al. 2000a). DAPI
counterstain was applied, and cells were viewed with a
Zeiss Axiophot fluorescent microscope equipped with
both single-band pass filters and a triple-band pass filter.
Digital images were captured by a Power Macintosh G3
system and MacProbe version 4.0 or 4.3 (Perceptive Sci-
entific Instruments). In each subject in whom a derivative
chromosome 1 was found, the parent of origin was
screened by FISH to determine whether the 1p36 dele-
tion was caused by malsegregation of a parental trans-
location or a de novo event, or if it was perhaps asso-
ciated with a familial polymorphism (Ballif et al. 2000b).
Results
Molecular Characterization of Deletions
Physical Map of 1p36 and Construction of a Natural
Deletion Panel.—Marker order was initially assigned on
the basis of information available through the Wellcome
Trust Sanger Institute and the Human Chromosome 1
Home Page. Deletion sizes were determined in all 61
subjects. Deletion sizes were characterized initially from
analyses of 25 microsatellite markers in each subject.
The deletions ranged from 1.5 Mb to 110.5 Mb. We
then assembled a minimal tiling path contig of 99 large-
insert clones over the most distal 10.5 Mb of 1p36. This
region was chosen because it contains most of the break-
points from our subjects (fig. 2). This contig has five
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Figure 3 Breakpoint locations of 60 1p36 deletions. Breakpoint clustering was plotted as a histogram of the total number of breakpoints
within each 0.5-Mb bin of the terminal 10.5 Mb of 1p36. All breakpoints are included for those subjects with multiple breakpoints due to
interstitial deletions or complex rearrangements.
sequence gaps, with the first gap, between clone RPCI5-
857K21 and the telomere, estimated to be !300 kb
(Knight et al. 2000). The second gap is between RPCI1-
286D6 and RPCI11-495K24 and is ∼300 kb. The third
gap, between RPCI5-1096P7 and RPCI11-30J10, and
the fourth gap, between RPCI4-703E10 and RPCI1-
58B11, are estimated to be !100 kb. The final gap, be-
tween RPCI11-476D13 and RPCI13-392I16, is ∼400
kb. Gap size estimates (except for the most telomeric
gap) are based on fiber FISH or fingerprinting experi-
ments performed at the Wellcome Trust Sanger Institute
(S. Gregory, personal communication). This contig pro-
vided a framework from which deletion sizes were fur-
ther refined into 0.5-Mb “bins,” by means of FISH, using
these large-insert clones as probes. Many of the break-
points were localized within a single clone or within two
overlapping clones (fig 2). The analysis of the subject
breakpoint locations and assessment of deletion sizes
formed the natural deletion panel. This natural deletion
panel aided in the correct ordering and orientation of
BAC/PAC clones and subsequently confirmed or clarified
our physical map.
During the construction of the natural deletion panel,
each breakpoint was placed on the contig. Thus, for
terminal deletions, one breakpoint was mapped. For
four subjects with interstitial deletions (subjects 1, 10,
17, and 18), two breakpoints were placed on the map,
and for three subjects with complex rearrangements
(subjects 3, 9, and 45), each breakpoint—three or four,
depending on the rearrangement—was placed on the
map. Three breakpoints were not mapped within a 0.5-
Mb bin, because they were 110.5 Mb from the telomere
(fig. 2). Deletion sizes ranged widely, but most break-
points (12.5%) clustered 4.0–4.5 Mb from the telomere.
Forty percent of all breakpoints occurred 3.0–5.0 Mb
from the telomere (fig. 3).
Classification of Rearrangements.—To distinguish be-
tween terminal deletions, interstitial deletions, and de-
rivative chromosomes, telomere region–specific FISH
probes further characterized 27 cases, since 33 subjects
were characterized previously (Ballif et al. 2000a). In
addition, a clone that maps to the 1p TAR region was
used to further clarify the apparently pure terminal de-
letions. We found that 43 subjects (72%) with mono-
somy 1p36 appeared to have true terminal deletions in
which the most distal known unique 1p subtelomeric
sequence was absent and not replaced by another chro-
mosome end (table 2; fig. 4A). In these cases, the
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Table 2
Study Subjects Included in This Investigation
Study
Subject
Age at
Diagnosis Sex
Clinical
Protocol
Parental
Origina Rearrangement
1 11 years M  Maternal Interstitial
2 10 years F  Maternal Terminal
3 Unknown M  Unknown Complex
4 5 years F  Maternal Terminal
5 2 years M  Maternal Derivative
6 2 years F  Maternal Terminal
7 2 years M  Maternal Terminal
8 Prenatal F  Paternal Terminal
9 1 mo F  Maternal Complex
10 Birth M  Maternal Interstitial
11 10 years F  Maternal Terminal
12 Birth M  Paternal Terminal
13 7 mo M  Paternal* Derivative
14 7 mo F  Maternal Terminal
15 8 years F  Paternal Derivative
16 1 year F  Maternal Terminal
17 1 year F  Maternal Interstitial
18 Unknown F  Paternal Interstitial
19 Prenatal F  Maternal Derivative
20 Unknown F  Maternal Terminal
21 2 years F  Maternal Terminal
22 Unknown F  Paternal Terminal
23 2 years M  Maternal Terminal
24 Unknown F  Paternal Terminal
25 14 years F  Unknown Terminal
26 Birth F  Maternal Derivative
27 Unknown F  Maternal Terminal
28 1.5 year F  Maternal Terminal
29 Prenatal F  Maternal Derivative
30 1.5 year M  Maternal Terminal
31 Prenatal F  Maternal Derivative
32 6 years M  Unknown Terminal
33 Unknown M  Maternal Terminal
34 Unknown F  Paternal Terminal
35 Unknown M  Maternal Terminal
36 9 mo F  Paternal Terminal
37 1 year F  Maternal Terminal
38 Birth M  Maternal Terminal
39 Birth M  Paternal Terminal
40 8 mo F  Maternal Terminal
41 14 mo F  Paternal Terminal
42 1 year M  Maternal* Derivative
43 6 mo M  Paternal Terminal
44 2 years M  Unknown Derivative
45 Birth M  Maternal Complex
46 Birth F  Maternal Terminal
47 7 mo F  Paternal Terminal
48 Unknown M  Maternal Terminal
49 Birth F  Paternal Terminal
50b Prenatal F  Unknown Unknown
51 7 years F  Unknown Terminal
52 3 mo F  Paternal Terminal
53 Unknown F  Paternal Terminal
54 Unknown F  Paternal Terminal
55a 1 year M  Maternal* Derivative
55b 8 years F  Maternal* Derivative
56 10 mo F  Maternal Terminal
57 2 years M  Maternal Terminal
58 19 years F  Paternal Terminal
59 3 years M  Maternal Terminal
60 Unknown M  Maternal Terminal
61 1.5 years F  Paternal Terminal
a Parental origin of the chromosome with deletion of 1p36 is de novo in
all cases, except those indicated with an asterisk (*).
b Study subject 50 is included in the table for completeness but was not
evaluated for deletion size, parental origin, or type of rearrangement.
(TTAGGG)n telomeric repeat probe was present in each
(data not shown). Of 60 deletions, 4 (7%) were inter-
stitial, retaining either the 1p subtelomeric region or the
1p TAR (table 2; fig. 4B). Ten subjects (17%) had a
derivative chromosome 1 in which the 1p telomeric re-
gion was replaced by another chromosome end (table 2;
fig. 4C); three of these resulted from malsegregation of
balanced parental translocations, and seven were de
novo. The derivative chromosomes included addition of
the telomeric regions from 1q in three cases, 22q in two
cases, and one case each of 2p, 8p, 9q, 15p, and Xp. In
addition, three subjects (subjects 3, 9, and 45) had more
complex rearrangements (fig. 4D). Subjects 3 and 9 had
interstitial deletions, which also retained a small piece
of distal chromosome 1p36. Subject 45 had a terminal
deletion of chromosome 1p36, retention of some prox-
imal 1p36 material, and another, more proximal deleted
region. Both microsatellite analysis and FISH confirmed
each of these complex rearrangements.
Parental Origins of Deletions.—The parental origin of
the chromosome with the deletion was determined in 40
of the 43 subjects with de novo terminal deletions (table
2). In two cases, we were unable to identify informative
markers in the deleted region, and, in one case, neither
parental sample was available. Twenty-four (60%) were
derived from the maternally inherited chromosome, and
16 (40%) arose from the paternally inherited chromo-
some. In general, deletions of paternal origin were larger
than deletions derived from the maternally inherited
chromosome. Of those with de novo terminal deletions,
75% of maternal deletions were !5.0 Mb, whereas
62.5% of paternal breakpoints were 15.0Mb. We ap-
plied a Fisher’s exact probability test (Fisher’s Exact Sta-
tistical Analysis Web site) to compare the number of de
novo maternal and paternal breakpoints that were !5.0
Mb to those that were 15.0 Mb. We found a significant
difference ( ), with more maternally derivedPp .02
smaller deletions.
If all rearrangements are considered, 65% of deletions
were from the maternally derived chromosome, and
35% were from the paternally derived chromosome.
When we compared all breakpoints for size and parental
origin by Fischer’s exact probability test, including mul-
tiple breakpoints from those with complex deletions and
interstitial deletions, a significant difference was found.
Most maternally derived deletions were !5.0 Mb, and
most paternally derived deletions were 15.0 Mb (Pp
)..013
Clinical Characterization of 30 Subjects
with Monosomy 1P36
Craniofacial and Ophthalmological Features.—The fa-
cial characteristics of these subjects are remarkably sim-
ilar. Common features include microcephaly, brachy-
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Table 3
Frequency of Clinical Features of Monosomy 1p36
Clinical Feature
No. of Study
Subjects/Total
Evaluated (%)
Physical characteristics:
Large anterior fontanel 22/26 (85)
Microcephaly 18/30 (60)
Brachycephaly 18/30 (60)
Deep-set eyes 24/30 (80)
Flat nasal bridge 23/30 (77)
Flat nose 20/30 (67)
Thickened ear helices 16/30 (53)
Asymmetric ears 16/30 (53)
Posteriorly rotated ears 7/30 (23)
Low-set ears 7/30 (23)
Pointed chin 20/30 (67)
Short fifth finger 26/30 (87)
Fifth-finger clinodactyly 12/30 (40)
Clefting abnormalities:
Orofacial clefting anomalies 5/30 (17)
Ophthalmological findings:
Hypermetropia 20/30 (67)
Visual inattentiveness 9/30 (30)
Strabismus 9/30 (30)
Myopia 5/30 (17)
Nystagmus 4/30 (13)
Endocrinological findings:
Hypothyroidism 6/30 (20)
Neurological findings:
Developmental delay/mental retardation 30/30 (100)
Hypotonia 26/30 (87)
Oropharyngeal dysphasia 21/29 (72)
Feeding difficulties in infancy 19/30 (63)
Epilepsya 15/31 (48)
Cardiovascular findings:
Dilated cardiomyopathy 7/30 (23)
Patent ductus arteriosus 5/30 (17)
Ventricular septal defect 4/30 (13)
Dilated aortic root 3/30 (10)
Atrial septal defect 2/30 (7)
Left-ventricular dilation without cardiomyopathy 2/30 (7)
Bicommisural aortic valve 2/30 (7)
Ebstein anomaly 1/30 (3)
Auditory findings:
Hearing loss 23/28 (82)
a One patient did not participate in the full evaluation but did have
a history of seizures and therefore was included.
cephaly, deep-set eyes, flat nose and nasal bridge, and
pointed chin (fig. 1; table 3). By history or direct physical
examination, 85% had a large or late-closing anterior
fontanel. Other features include overt clefting abnor-
malities, in 17% of subjects. This included one patient
with cleft lip and palate, one with cleft lip only, and
three with minor palatal clefting abnormalities such as
submucous occult cleft and bifid uvula. Five subjects had
a high-arched palate but no overt clefting on examina-
tion, and one patient had a history of a cricoid cleft.
Visual inattentiveness, defined as absence of attentive
visual behavior with fixation and following movements,
was seen in 30% of subjects. Other ophthalmological
findings are shown in table 3.
Endocrinological Findings.—Two subjects had previ-
ously diagnosed hypothyroidism and were on thyroid
supplementation at the time of this survey. Baseline thy-
roid studies on the remaining subjects showed that four
others had elevated thyroid stimulating hormone (TSH)
levels with corresponding low T4 levels; thus, six sub-
jects (20%) had chemical hypothyroidism.
Neurological Manifestations.—All subjects had mental
retardation of varying degrees, as assessed with a num-
ber of neuropsychiatric tests (Shapira et al. 1997), de-
pending on the age of the subject. Fifty-eight percent of
subjects had a history of seizures, including 48% with
chronic seizures (epilepsy) who required continuing anti-
convulsant medications. The types of seizures included
generalized tonic-clonic, myoclonic, partial complex,
and infantile spasms. The seizure histories and EEGs in
the first 24 subjects have been reported elsewhere (Heil-
stedt et al. 2001). By report, 87% of subjects were de-
scribed as hypotonic in infancy, and 63% had histories
of feeding problems, including poor suck and swallow,
reflux, and vomiting in infancy. Three subjects required
gastric tubes for feeding difficulties, and 72% had oro-
pharyngeal dysphasia on swallow studies, which ranged
from mild to severe.
Cardiovascular Findings.—Seven subjects (23%) had
a history of dilated cardiomyopathy in infancy. None
worsened over time, although three subjects continued
on medication at the time of the evaluations. Thirteen
subjects (43%) had a structural heart defect, most fre-
quently patent ductus arteriosus (table 3).
Hearing Evaluation.—Complete auditory evaluation,
which included testing at high frequencies (6–8 kHz),
was obtained on 28 subjects. Testing was performed by
ABER or sound field evaluation. Eighty-two percent of
subjects had some hearing impairment. Eleven subjects
had mild high-frequency sensorineural hearing impair-
ment (130–50 db loss by tone burst), and 12 subjects
had more severe hearing impairment at all frequencies.
Only two had conductive hearing loss.
Genotype-Phenotype Correlation
The relative order and approximate location of 90
known genes or full-length mRNAs were identified by a
comparative analysis of the annotated genomic sequence
of 1p36 from three genome browsers (Ensembl; NCBI
Home Page; UCSC Genome Bioinformatics Home). A
clone-by-clone sequence analysis of the 99 clones in our
10.5-Mb contig of 1p36 was also performed with the U.K.
Human Genome Mapping Resource Centre’s bioinfor-
matics application, NIX (NIX Web site). NIX uses BLAST
analyses and multiple gene-prediction programs to iden-
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tify various important elements within an unknown nu-
cleic acid sequence. Fifty-one of the genes were identified
by each of the four approaches, 29 were identified by
three of the four approaches, and only two of the four
approaches identified 10 of the genes. This list of the gene
content of 1p36 is not exhaustive, because only known
genes and full-length mRNAs were included. Many other
novel genes may reside within 1p36, but, because of the
extensive variations in the annotations of the human ge-
nome by the browsers used, putative novel genes were
not included in our analyses. For those subjects in whom
adequate clinical information is available, the critical
regions for certain features are depicted in figure 5. These
critical regions are based on the subject with the smallest
deletion with a given phenotypic feature.
Discussion
To define more precisely the types and sizes of deletions
of 1p36, we constructed a physical map of the most
distal 10.5 Mb of 1p36. From this physical map, we
created a natural deletion panel of subjects with 1p36
deletions and have localized the breakpoints to within
0.5-Mb bins. This deletion panel assigned the appro-
priate location and orientation of large-insert clones and
markers found on the various public databases. In sev-
eral subjects, the breakpoints were contained within
large-insert clones. The deletion sizes in subjects with
monosomy 1p36 were quite variable, although there was
some breakpoint clustering 4.0–4.5 Mb from the telo-
mere. This variability confounds the prediction of a com-
mon mechanism for these deletions, as has been pos-
tulated for other deletion syndromes, such as DiGeorge
syndrome (Edelman et al. 1999) and Smith-Magenis syn-
drome (Chen et al. 1997), in which low-copy repeats
mediate homologous recombination between nonallelic
regions. The reason that deletions of 1p36 are observed
with a relatively high population frequency of 1 in 5,000
(Shaffer and Lupski 2000) remains unknown.
We identified true terminal deletions, interstitial dele-
tions, derivative chromosomes, and complex rearrange-
ments of 1p36. Conventional cytogenetics may not dis-
tinguish these different rearrangements, especially those
that are derivative chromosomes. In our study, three sub-
jects had a derivative chromosome 1 inherited from a
parent with a balanced translocation. Only two of these
were seen cytogenetically. The third derivative chromo-
some could be detected only with subtelomere region–
specific FISH probes. A balanced parental translocation
substantially increases the risk of recurrence of an un-
balanced event in a family. Therefore, FISH with sub-
telomeric region–specific probes should be considered in
all cases of monosomy 1p36, to detect double segmental
imbalances and to identify parental rearrangements.
However, ∼10% of our subjects had interstitial deletions,
and most would be interpreted as normal if just the sub-
telomeric FISH probe were used. Thus, additional probes
may be necessary to uncover deletions. Our results show
that some cytogenetically defined terminal deletions of
1p36 may be more complex than simple telomeric trun-
cations, and, on the basis of this observation, we suggest
that these terminal deletions may be formed by a variety
of mechanisms.
The de novo deletions occurred mostly on the maternal
chromosomes, although the larger deletions tended to
occur on the paternal chromosomes. The sex-specific
breakpoint clustering is currently under further investi-
gation. No obvious differences in phenotype could be
interpreted solely from the parent-of-origin studies.
The clinical phenotypes in 30 subjects with mono-
somy 1p36 have been defined carefully in this study.
No subject in our study had a history of cancer (10 mo
to 13 years of age at evaluation). This observation may
be due to (i) the age of our patient population, (ii) the
small number of subjects in this study compared with
the incidence of various cancers such as neuroblastoma,
or (iii) possible parent-of-origin effects among varying-
sized deletions in the development of cancer, most no-
tably neuroblastoma (Wu et al. 1999).
Double segmental imbalance was present in the 10
subjects who had derivative chromosomes. Clinical in-
formation is available on only four of these subjects,
those who were included in the GCRC protocol. Subject
13 has duplication of distal 22q in addition to deletion
of 1p36, and subject 15 has duplication of distal 1q in
addition to deletion of 1p36. These subjects are some-
what more delayed than comparable subjects with pure
1p36 deletion, although this is a nonspecific finding, in
that the degree of delay is quite variable in this syn-
drome in patients with similar-sized deletions. Subject
19 has duplication of 15p in addition to deletion of
1p36. Because the short arm of chromosome 15 con-
tains the ribosomal RNA genes and repetitive DNA,
addition of this genetic material is unlikely to contribute
to any phenotypic findings. Subjects 55a and 55b have
duplication of distal 9q in addition to deletion of 1p36.
These unbalanced translocations are due to malsegre-
gation of a maternal translocation. Any contribution of
9q trisomy to the phenotype cannot be identified. These
two subjects are somewhat different in their clinical
presentations, with subject 55a having the characteristic
large anterior fontanelle, which was absent in subject
55b, who is more delayed than subject 55a. However,
these findings are within the usual variation seen in this
syndrome. The variability in their clinical presentations
is interesting, given that these two subjects have differ-
ent fathers. This family demonstrates the difficulty in
identifying small regions in which to search for genes
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to particular clinical features, because the clinical pres-
entations can be variable even within families.
The constellation of facial features, including deep-
set eyes, flat nasal bridge, flat nose, and pointed chin,
leads to a clinically recognizable facial phenotype (fig.
1). The medical evaluations from the present study sug-
gest that selected testing should be performed on all
patients with monosomy 1p36. For example, hearing
impairment appears to be quite common, occurring in
82% of study subjects. Many subjects had mild sen-
sorineural hearing loss at the high frequencies (6–8
kHz). In more basic audiological evaluations, high-fre-
quency hearing impairment would be missed, because
these frequencies are not always tested, since they do
not affect speech reception. However, the identification
of mild hearing loss is important for appropriate follow-
up testing. In addition, accurate diagnoses are critical
to narrow the regions in which to search for causative
genes. Thus, full audiometric evaluations, including
testing at high frequencies, should be performed, and,
because the hearing impairment has been progressive in
some patients, yearly evaluations are suggested.
Seizures occurred in approximately half of subjects, so
all patients should be monitored for seizure activity.
Twenty percent of subjects in this study had chemical
hypothyroidism requiring thyroxin supplementation.
Hypothyroidism was reported recently in two unrelated
patients with 1p36 deletions (Zenker et al. 2002). There-
fore, we recommend that all patients with monosomy
1p36 be evaluated for thyroid dysfunction by T4, free
T4, and TSH levels at birth, at 6 mo, and then annually.
Palatal abnormalities were found in 17% of subjects and,
thus, the palate should be evaluated, because these ab-
normalities can affect feeding and can compound both
hearing loss and speech development. Oropharyngeal
dysphagia was found in most study subjects (72%).
Therefore, swallow-function studies should be included
in the initial evaluation of patients with monosomy 1p36,
to assess the need for oromotor intervention. Ophthal-
mological evaluation is encouraged, because 83% of
study subjects had notable visual disorders, including
substantial refractive errors. Dilated cardiomyopathy has
been reported previously to occur in monosomy 1p36
(Keppler-Noreuil et al. 1995; Slavotinek et al. 1999); we
found that nearly a quarter of our study subjects had this
cardiac finding. However, a larger number of subjects
(43%) had various structural cardiac abnormalities, sug-
gesting that an echocardiogram should be included in the
evaluation of patients with this deletion.
Because the deletions in monosomy 1p36 are variable,
genotype-phenotype correlations may be useful to lo-
cate the genes responsible for several clinical features
of the syndrome. The phenotypic features tend to vary
with the size of the deletion, and study subjects with
larger deletions tend to have more phenotypic features
(Wu et al. 1999). Diligent clinical evaluation assists in
the characterization of this genotype-phenotype corre-
lation. We have used this approach to identify candidate
genes associated with an epilepsy phenotype (Heilstedt
et al. 2001) and clefting abnormalities (Colmenares et
al. 2002). We anticipate that other genes, when hap-
loinsufficient, result in other phenotypic features of the
syndrome. Identification of genes involved in specific
phenotypic features of this syndrome could potentially
lead to more-precise treatments for individuals with
1p36 deletions and might identify mutations for single-
gene disorders. We have elucidated potential critical
regions for certain clinical findings in monosomy 1p36
(fig. 5). Although the terminal region of chromosome
1p36 is gene rich, only some of these genes will lead to
a specific phenotype when deleted. Nonpenetrance, epi-
genetic, and stochastic factors may influence certain
clinical features and would not allow the critical regions
to be precisely defined. Characterization of more study
subjects with small or complex deletions and accurate
clinical assessment may refine some of these critical
regions.
Because of diversity in both the types and sizes of
cytogenetic anomalies in monosomy 1p36, these rear-
rangements should be investigated with a variety of
FISH probes and/or polymorphic markers. Appropriate
genetic counseling and accurate assessment of recur-
rence risks are contingent on a thorough analysis. Al-
though monosomy 1p36 is the most commonly ob-
served terminal deletion in the human population, the
basis for its relatively high frequency remains unclear.
Cloning and characterization of breakpoints should
suggest mechanisms involved in generating deletions of
1p36.
Acknowledgments
We thank the families who participated in this study, the
numerous physicians and genetic counselors who referred these
study subjects, P. Pierce (Baylor College of Medicine) for as-
sistance in travel arrangements for patients, and J. Williams
and the nursing staff of the TCH-GCRC, Houston. We are
grateful to the Kleberg Cytogenetics Laboratory, Baylor Col-
lege of Medicine, for initial karyotype and FISH analyses, and
to S. Gregory and the staff of the Wellcome Trust Sanger In-
stitute, for sequence information, clones, and fiber FISH data
on the gap regions. This study was supported, in part, by
National Institutes of Health (NIH) National Institute of
Deafness and Other Communication Disorders grant K08
DC00169 (to H.A.H.), Baylor College of Medicine Mental
Retardation Research Center grant NIH P30 HD24064 (to
L.G.S.), NIH National Institute for Child Health and Devel-
opment grant P01 HD39420 (to L.G.S.), the Simmons Foun-
dation (support to L.G.S.), the Gillson Longenbaugh Foun-
dation (support to L.G.S.), Texas Children’s Hospital General
Clinical Research Center grant NIH MO1 RR00188, and un-
Heilstedt et al.: del(1)(p36) Molecular Characterization 1211
restricted funds from Research to Prevent Blindness, New York
(to R.A.L.).
Electronic-Database Information
The URLs for data presented herein are as follows:
Ensembl, http://www.ensemble.org/
Fisher’s Exact Statistical Analysis, http://faculty.vassar.edu/
lowry/fisher.html
GenBank, http://www.ncbi.nlm.nih.gov/Genbank (for BAC
and PAC clones listed in fig. 2)
Human Chromosome 1 Home Page, http://compgen.rutgers
.edu/chr1/resources/index.shtml
NCBI Home Page, http://www.ncbi.nlm.nih.gov/
UCSC Genome Bioinformatics Home, http://genome.ucsc.edu
U.K. Human Genome Mapping Resource Center Bioinfor-
matics Applications: NIX, http://www.hgmp.mrc.ac.uk/
Registered/Webapp/nix/
Wellcome Trust Sanger Institute, Human Chromosome 1
Home, http://www.sanger.ac.uk/HGP/Chr1/
References
Ballif BC, Kashork CD, Shaffer LG (2000a) FISHing for mech-
anisms of cytogenetically defined terminal deletions using
chromosome-specific subtelomeric probes. Eur J Hum Genet
8:764–770
——— (2000b) The promise and pitfalls of telomere region–
specific probes. Am J Hum Genet 67:1356–1359
Blatt J (2001) Tumor suppressor genes on the short arm of
chromosome 1 in neuroblastoma. Pediatr Hematol Oncol
18:3–5
Chen KS, Manian P, Koeuth T, Potocki L, Zhao Q, Chinault
AC, Lee CC, Lupski JR (1997) Homologous recombination
of a flanking repeat gene cluster is a mechanism for a com-
mon contiguous gene deletion syndrome. Nat Genet 17:154–
163
Colmenares C, Heilstedt HA, Shaffer LG, Schwartz S, Berk
M, Murray JC, Stavnezer E (2002) Loss of the SKI proto-
oncogene in individuals affected with 1p36 deletion syn-
drome is predicted by strain-dependent defects in Ski/
mice. Nat Genet 30:106–109
Edelmann L, Pandita RK, Spiteri E, Funke B, Goldberg R,
Palanisamy N, Chaganti RS, Magenis E, Shprintzen RJ,
Morrow BE (1999) A common molecular basis for rear-
rangement disorders on chromosome 22q11. Hum Mol Ge-
net 8:1157–1167
Flint J, Bates GP, Clark K, Dorman A, Willingham D, Roe BA,
Micklem G, Higgs DR, Louis EJ (1997) Sequence compar-
ison of human and yeast telomeres identifies structurally
distinct subtelomeric domains. Hum Mol Genet 6:1305–
1314
Heilstedt HA, Burgess DL, Anderson AE, Chedrawi A, Tharp
B, Lee O, Kashork CD, Starkey DE, Wu YQ, Noebels JL,
Shaffer LG, Shapira SK (2001) Loss of the potassium chan-
nel beta-subunit gene, KCNAB2, is associated with epilepsy
in patients with 1p36 deletion syndrome. Epilepsia 42:
1103–1111
Keppler-Noreuil KM, Carroll AJ, Finley WH, Rutledge SL
(1995) Chromosome 1p terminal deletion: report of new
findings and confirmation of two characteristic phenotypes.
J Med Genet 32:619–622
Knight SJ, Horsley SW, Regan R, Lawrie NM, Maher EJ,
Cardy DL, Flint J, Kearney L (1997) Development and clin-
ical application of an innovative fluorescence in situ hy-
bridization technique which detects submicroscopic rear-
rangements involving telomeres. Eur J Hum Genet 5:1–8
Knight SJ, Lese CM, Precht KS, Kuc J, Ning Y, Lucas S, Regan
R, Brenan M, Nicod A, Lawrie NM, Cardy DL, Nguyen H,
Hudson TJ, Riethman HC, Ledbetter DH, Flint J (2000) An
optimized set of human telomere clones for studying telo-
mere integrity and architecture. Am J Hum Genet 67:320–
332
Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL,
Jones MD, Meyne J, Ratliff RL, Wu JR (1988) A highly
conserved repetitive DNA sequence, (TTAGGG)n, present
at the telomeres of human chromosomes. Proc Natl Acad
Sci USA 85:6622–6626
Nelson MA, Ariza ME, Yang JM, Thompson FH, Taetle R,
Trent JM, Wymer J, Massey-Brown K, Broome-Powell M,
Easton J, Lahti JM, Kidd VJ (1999) Abnormalities in the
p34cdc2-related PITSLRE protein kinase gene complex
(CDC2L) on chromosome band 1p36 in melanoma. Cancer
Genet Cytogenet 108:91–99
Nelson MA, Radmacher MD, Simon R, Aickin M, Yang J,
Panda L, Emerson J, Roe D, Adair L, Thompson F, Bangert
J, Leong SP, Taetle R, Salmon S, Trent J (2000) Chromosome
abnormalities in malignant melanoma: clinical significance
of nonrandom chromosome abnormalities in 206 cases.
Cancer Genet Cytogenet 122:101–109
Saccone S, De Sario A, Valle GD, Bernardi G (1992) The high-
est gene concentrations in the human genome are in the
telomeric bands of metaphase chromosomes. Proc Natl Acad
Sci USA 89:4913–4917
Shaffer LG, Heilstedt HA (2001) Terminal deletion of 1p36.
Lancet 358:S9
Shaffer LG, Lupski JR (2000) Molecular mechanisms for con-
stitutional chromosomal rearrangements in humans. Annu
Rev Genet 34:297–329
Shaffer LG, McCaskill C, Han JY, Choo KH, Cutillo DM,
Donnenfeld AE, Weiss L, Van Dyke DL (1994) Molecular
characterization of de novo secondary trisomy 13. Am J
Hum Genet 55:968–974
Shaffer LG, Overhauser J, Jackson LG, Ledbetter DH (1993)
Genetic syndromes and uniparental disomy: a study of 16
cases of Brachmann-de Lange syndrome. Am J Med Genet
47:383–386
Shapira SK, McCaskill C, Northrup H, Spikes AS, Elder FF,
Sutton VR, Korenberg JR, Greenberg, F, Shaffer LG (1997)
Chromosome 1p36 deletions: the clinical phenotype and
molecular characterization of a common newly delineated
syndrome. Am J Hum Genet 61:642–650
Slavotinek A, Shaffer LG, Shapira SK (1999) Monosomy 1p36.
J Med Genet 36:657–663
Thompson FH, Taetle R, Trent JM, Liu Y, Massey-Brown K,
Scott KM, Weinstein RS, Emerson JC, Alberts DS, Nelson
MA (1997) Band 1p36 abnormalities and t(1;17) in ovarian
carcinoma. Cancer Genet Cytogenet 96:106–110
White PS, Maris JM, Beltinger C, Sulman E, Marshall HN,
1212 Am. J. Hum. Genet. 72:1200–1212, 2003
Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C,
Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur
GM (1995) A region of consistent deletion in neuroblastoma
maps within human chromosome 1p36.2-36.3. Proc Natl
Acad Sci USA 92:5520–5524
Wu Y-Q, Heilstedt H, Bedell JA, May KM, Starkey DE, Mc-
Pherson JD, Shapira SK, Shaffer LG (1999) Molecular re-
finement of the 1p36 deletion syndrome reveals size diversity
and a preponderance of maternally derived deletions. Hum
Mol Genet 8:313–321
Zenker M, Rittinger O, Grosse K-P, Speicher MR, Kraus J,
Rauch A, Trautmann U (2002) Monosomy 1p36-a recently
delineated, clinically recognizable syndrome. Clin Dysmor-
phol 11:43–48
